Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China | stella

Learn About Find trials matched to me

About Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China | stella

Back to Chronic Myeloid Leukemia in Chronic Phase trials

Recruiting

Trial locations(1 site)

China

Novartis Investigative Site, Wuhan, Hubei

Key details

Sponsor

Novartis Pharmaceuticals

Enrollment target

~200 participants

Started

February 2026

Primary completion

December 2028

Age range

18 Years – 99 Years

Last updated on clinicaltrials.gov in April 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Novartis Pharmaceuticals

Novartis Pharmaceuticals

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Enrollment status is pulled from ClinicalTrials.gov and may not reflect real-time availability. If a trial appears full when you reach out, the team will let you know.

Your name

Email address

View full record on ClinicalTrials.gov

Follow this trial

Get notified in plain English when this trial's status changes. No account required.